Skip to content

TuHURA Biosciences, Inc. HURA Payments To Acquire Business Two Net Of Cash Acquired

Payments To Acquire Business Two Net Of Cash Acquired at other companies

CBRE Group logo
CBRE GroupCBRE
$0-100%
Greif logo
GreifGEF
$5.3M+15.2%
MRD
Meridian Holdings, Inc. MRDN
$806.39K+89.0%
USANA Health Sciences logo
USANA Health SciencesUSNA
$0-100%
Acco Brands logo
Acco BrandsACCO
$1.1M-89.1%
Mercantile Bank Corporation logo
Mercantile Bank CorporationMBWM
-$13.39M

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessTwoNetOfCashAcquired.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed August 14, 2025, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s payments to acquire business two net of cash acquired.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s payments to acquire business two net of cash acquired?
TuHURA Biosciences, Inc. (HURA) reported payments to acquire business two net of cash acquired of $150.9K in Q2 2025.